CGRP as a new target in prevention and treatment of migraine Comment

被引：20
|
作者：
Diener, Hans-Christoph [1 ,2 ]
机构：
[1] Univ Duisburg Essen, Dept Neurol, Univ Hosp Essen, D-45147 Essen, Germany
[2] Univ Duisburg Essen, Headache Ctr, Univ Hosp Essen, D-45147 Essen, Germany
来源：
LANCET NEUROLOGY | 2014年 / 13卷 / 11期
关键词：
RANDOMIZED CONTROLLED-TRIAL; GENE-RELATED PEPTIDE; DOUBLE-BLIND; RECEPTOR;
D O I：
10.1016/S1474-4422(14)70228-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1065 / 1067
页数：3
相关论文
共 50 条
  • [21] CGRP antagonists and antibodies for the treatment of migraine
    Vecsei, Laszlo
    Szok, Delia
    Csati, Anett
    Tajti, Janos
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (01) : 31 - 41
  • [22] CGRP receptor antagonists for the treatment of migraine
    Bell, Ian M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [23] CGRP antagonists in the acute treatment of migraine
    Lipton, RB
    Dodick, DW
    LANCET NEUROLOGY, 2004, 3 (06): : 332 - 332
  • [24] Recognizing the role of CGRP and CGRP receptors in migraine and its treatment
    Edvinsson, Lars
    Warfvinge, Karin
    CEPHALALGIA, 2019, 39 (03) : 366 - 373
  • [25] The Journey to Establish CGRP as a Migraine Target: A Retrospective View
    Edvinsson, Lars
    HEADACHE, 2015, 55 (09): : 1249 - 1255
  • [26] Clinical characteristics of patients who preferred migraine prevention treatment with CGRP monoclonal antibodies
    Vashchenko, N.
    Skorobogatykh, K.
    Azimova, J.
    Korobkova, D.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 122 - 122
  • [27] CGRP - a target for acute therapy in migraine: Clinical data
    Messina, Roberta
    Goadsby, Peter J.
    CEPHALALGIA, 2019, 39 (03) : 420 - 427
  • [28] Clinical characteristics of patients who preferred migraine prevention treatment with CGRP monoclonal antibodies
    Vashchenko, N.
    Skorobogatykh, K.
    Azimova, J.
    Korobkova, D.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 182 - 182
  • [29] NEW OPTIONS FOR MIGRAINE TREATMENT: FOCUS ON CGRP-BLOCKING ANTIBODIES
    Dux, M. J.
    Messlinger, K. B.
    DRUGS OF THE FUTURE, 2015, 40 (09) : 589 - 599
  • [30] Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumab
    Al-Khazali, Haidar M.
    Ashina, Hakan
    Christensen, Rune Hackert
    Wiggers, Astrid
    Rose, Kathrine
    Iljazi, Afrim
    Amin, Faisal Mohammad
    Ashina, Messoud
    Snellman, Josefin
    Maio-Twofoot, Tina
    Schytz, Henrik W.
    CEPHALALGIA, 2024, 44 (06) : 3331024241258734
12345